Sutro Biopharma Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
STROUDS INC
Did you know?
Holds 3.8x more cash than debt — a strong balance sheet.
Current Price
—
GoodMoat Value
$58.24
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Sutro Biopharma Inc (STRO) Stock Analysis
Market Cap—
Current Price—
P/E Ratio—
Forward P/E—
PEG Ratio—
EPS—
Book Value—
P/B Ratio—
STRO Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 43M
Revenue
43M
FY19
43M
FY20
62M
FY21
68M
FY22
154M
FY23
62M
FY24
102M
FY25
Net Income
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Did you know?
STRO's revenue grew at a 15.7% CAGR over the last 6 years.
Sutro Biopharma Inc (STRO) Financial Summary
Sutro Biopharma Inc (STRO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ..
..
STRO Key Financial Metrics
| Metric | Value |
|---|
STRO Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $42.74M | $-55.74M |
| FY20 | $42.72M | $-32.13M |
| FY21 | $61.88M | $-105.54M |
| FY22 | $67.77M | $-119.20M |
| FY23 | $153.73M | $-106.79M |
| FY24 | $62.04M | $-227.46M |
| FY25 | $102.48M | $-191.09M |
Sutro Biopharma Inc (STRO) Valuation
Based on GoodMoat's DCF model, Sutro Biopharma Inc has a fair value estimate of $58.24.
About Sutro Biopharma Inc
STROUDS INC